Suppr超能文献

迷幻剂治疗结果项目(ATOP):塔基瓦西中心的一年期结果及其对迷幻科学的启示。

Ayahuasca Treatment Outcome Project (ATOP): One-Year Results from Takiwasi Center and Implications for Psychedelic Science.

机构信息

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Rory Meyers College of Nursing, New York University, New York, New York.

出版信息

J Stud Alcohol Drugs. 2024 Sep;85(5):607-618. doi: 10.15288/jsad.23-00005. Epub 2023 Aug 24.

Abstract

OBJECTIVE

This article focuses on the outcomes at 1 year post-treatment of a naturalistic evaluation of services provided through the Takiwasi Centre, an accredited Peruvian therapeutic community offering an ayahuasca-assisted, integrative treatment program for addiction rehabilitation.

METHOD

Participants ( = 52) completed structured interviews and a battery of validated instruments. Outcome measures included the Addiction Severity Index (Version 5), the Beck Anxiety and Depression Inventories, the World Health Organization Quality of Life Brief Version (WHOQOL-BREF), and the World Health Organization Quality of Life Spiritual Religious and Personal Belief (WHOQOL-SRPB) scale. Likert rating scales were used to assess perceived importance and significance of different aspects of the program and overall participant satisfaction.

RESULTS

The group change from baseline to the 1-year follow-up was significant and in the anticipated direction for alcohol and drug use severity, depression and anxiety, and some dimensions of quality of life. There was considerable individual variation in outcomes and treatment duration. The majority of participants rated all aspects of the program as important, including the spiritual and therapeutic significance of the ayahuasca experience, which was rated as very significant.

CONCLUSIONS

Based on the positive 1-year outcomes, and within the limitations of an uncontrolled observational study design, the findings suggest promise for the effectiveness of the use of ayahuasca in a multifactorial treatment context for individuals with significant treatment histories, high levels of comorbidity, and treatment motivation. Results highlight considerable variation in individual experience that merit in-depth qualitative analysis. Implications for ayahuasca-assisted and other psychedelic-assisted treatment alternatives are discussed.

摘要

目的

本文聚焦于塔基瓦西中心服务治疗效果的 1 年随访结果。塔基瓦西中心是一家经认证的秘鲁治疗社区,提供以安非他命类兴奋剂致瘾康复为目的的、包含使用植物致幻剂辅助治疗的综合性治疗方案。

方法

参与者(n=52)完成了结构式访谈和一系列验证工具的测试。评估的结果包括:成瘾严重程度指数(第 5 版)、贝克焦虑和抑郁量表、世界卫生组织生活质量简短量表(WHOQOL-BREF)和世界卫生组织生活质量精神宗教和个人信仰量表(WHOQOL-SRPB)。采用李克特量表来评估参与者对不同治疗方案和整体治疗满意度的重要性和意义。

结果

从基线到 1 年随访的时间内,该治疗方案显著改善了酒精和药物使用严重程度、抑郁和焦虑症状以及部分生活质量维度,变化方向与预期一致。但治疗效果在个体间存在显著差异,且治疗时间也存在差异。大多数参与者对治疗方案的所有方面都给予了高度评价,包括植物致幻剂治疗体验的精神和治疗意义,评价结果非常重要。

结论

基于积极的 1 年随访结果,以及非对照观察性研究设计的局限性,本研究结果表明,对于具有高治疗史、高共病率和高治疗动机的个体来说,在多因素治疗环境中使用植物致幻剂治疗具有潜在的有效性。研究结果突出了个体体验的巨大差异,这值得进行深入的定性分析。最后讨论了植物致幻剂辅助治疗及其他致幻剂辅助治疗方案的应用前景。

相似文献

8
Pharmacotherapy for anxiety and comorbid alcohol use disorders.焦虑症合并酒精使用障碍的药物治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.

本文引用的文献

3
Ayahuasca's therapeutic potential: What we know - and what not.阿亚瓦斯卡的治疗潜力:我们所知道的——以及未知的。
Eur Neuropsychopharmacol. 2023 Jan;66:45-61. doi: 10.1016/j.euroneuro.2022.10.008. Epub 2022 Nov 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验